BAG5
Gene Information
- Official Symbol: BAG5
- Official Name: BAG cochaperone 5
- Aliases and Previous Symbols: N/A
- Entrez ID: 9529
- UniProt: Q9UL15
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Inhibits both auto-ubiquitination of PRKN and ubiquitination of target proteins by PRKN (By similarity). May function as a nucleotide exchange factor for HSP/HSP70, promoting ADP release, and activating Hsp70-mediated refolding. {ECO:0000250, ECO:0000269|PubMed:20223214}.
Pfam Domains GO Terms
Pfam Domains
| BAG |
GO Terms
| regulation of protein refolding |
| negative regulation of protein refolding |
| negative regulation of protein folding |
| regulation of protein folding |
| negative regulation of ubiquitin-protein transferase activity |
| regulation of inclusion body assembly |
| inclusion body |
| negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
| negative regulation of cellular response to oxidative stress |
| negative regulation of oxidative stress-induced cell death |
| negative regulation of response to oxidative stress |
| negative regulation of ubiquitin-dependent protein catabolic process |
| regulation of ubiquitin-protein transferase activity |
| neuron death |
| negative regulation of proteasomal protein catabolic process |
| regulation of oxidative stress-induced cell death |
| negative regulation of proteolysis involved in cellular protein catabolic process |
| negative regulation of protein ubiquitination |
| regulation of cellular response to oxidative stress |
| regulation of cellular response to heat |
| negative regulation of protein modification by small protein conjugation or removal |
| regulation of response to oxidative stress |
| negative regulation of cellular protein catabolic process |
| negative regulation of intrinsic apoptotic signaling pathway |
| chaperone binding |
| regulation of proteasomal ubiquitin-dependent protein catabolic process |
| Golgi organization |
| negative regulation of protein catabolic process |
| regulation of ubiquitin-dependent protein catabolic process |
| negative regulation of neuron projection development |
| regulation of intrinsic apoptotic signaling pathway |
| protein stabilization |
| negative regulation of cell projection organization |
| regulation of proteasomal protein catabolic process |
| regulation of protein ubiquitination |
| regulation of proteolysis involved in cellular protein catabolic process |
| negative regulation of apoptotic signaling pathway |
| negative regulation of neuron differentiation |
| regulation of protein modification by small protein conjugation or removal |
| protein folding |
| regulation of cellular protein catabolic process |
| negative regulation of cellular catabolic process |
| negative regulation of transferase activity |
| regulation of protein stability |
| negative regulation of neurogenesis |
| ubiquitin protein ligase binding |
| negative regulation of catabolic process |
| negative regulation of nervous system development |
| negative regulation of cell development |
| negative regulation of proteolysis |
| regulation of protein catabolic process |
| regulation of apoptotic signaling pathway |
| endomembrane system organization |
| protein kinase binding |
| regulation of neuron projection development |
| negative regulation of intracellular signal transduction |
| negative regulation of protein modification process |
| regulation of neuron differentiation |
| regulation of plasma membrane bounded cell projection organization |
| perinuclear region of cytoplasm |
| negative regulation of cellular component organization |
| regulation of cell projection organization |
| negative regulation of cell differentiation |
| regulation of proteolysis |
| regulation of cellular response to stress |
| negative regulation of catalytic activity |
| regulation of neurogenesis |
| regulation of cellular catabolic process |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| regulation of nervous system development |
| regulation of cell development |
| negative regulation of developmental process |
| regulation of cellular component biogenesis |
| regulation of transferase activity |
| regulation of catabolic process |
| negative regulation of cell death |
| negative regulation of cellular protein metabolic process |
| cell death |
| negative regulation of protein metabolic process |
| negative regulation of molecular function |
| negative regulation of multicellular organismal process |
| mitochondrion |
| negative regulation of signal transduction |
| negative regulation of cell communication |
| negative regulation of signaling |
| regulation of response to stress |
| generation of neurons |
| regulation of apoptotic process |
| regulation of programmed cell death |
| negative regulation of response to stimulus |
| neurogenesis |
| regulation of cell death |
| regulation of cell differentiation |
| regulation of intracellular signal transduction |
| regulation of protein modification process |
| membrane |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| GSK343 3μM R03 exp124 | 1.74 |
Most Correlated Genes in Chemogenomics
No correlation found to any other genes in chemogenomics.
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 17440
- Expression level (log2 read counts): 6.61
Expression Distribution
BAG5 Expression in NALM6 Cells: 6.61